Switch to:
More From Other Websites
How Pfizer, Merck May Feel Long-Term Pinch From Brexit Jun 29 2016
How J&J Defied Brexit and Became the Year's Top Health Care Stock Jun 29 2016
Pfizer: Why a Big Acquisition is Needed After Possible Split Jun 29 2016
Pfizer's PCSK9 Inhibitor Tops Two Additional Phase III Studies Jun 29 2016
New partnership looks to improve lives of children living with HIV Jun 29 2016
Company News for June 29, 2016 Jun 29 2016
Research Report Initiated on Select Major Drug Manufacturers Equities Jun 29 2016
AstraZeneca’s cholesterol-drug gambit is the latest tactic from a company skilled at them Jun 29 2016
AstraZeneca’s cholesterol-drug gambit is the latest tactic from a company skilled at them Jun 29 2016
Why Pfizer Just Bet $350 Million On China (PFE) Jun 29 2016
Allergan Seeks Smaller M&A for Growth After Pfizer Breakup Jun 29 2016
Pfizer to Build $350M Biotech Center in China (PFE) Jun 28 2016
Pfizer Investing $350M in China Biotech Center Jun 28 2016
Pfizer Investing $350M in China, Setting up Biotech Center Jun 28 2016
Here’s Why Traders Are Watching These Stocks Today Jun 28 2016
Pfizer (PFE) Stock Gains on China Investment Jun 28 2016
Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : June 28, 2016 Jun 28 2016
Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results Jun 28 2016
8:33 am Pfizer announces two additional Phase 3 bococizumab trials met their primary endpoints Jun 28 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK